Callan Family Office’s CVS Health CVS Stock Holding History

Callan Family Office’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.1M	Sell	164,995 -108	-0.1%	-$9.64K	0.33%	56
2026 Q1	$11.9M	Buy	165,103 +9,799	+6%	+$755K	0.27%	73
2025 Q4	$12.3M	Buy	155,304 +19,988	+15%	+$1.58M	0.26%	71
2025 Q3	$10.2M	Buy	135,316 +14,208	+12%	+$974K	0.33%	60
2025 Q2	$8.35M	Buy	121,108 +89,053	+278%	+$5.84M	0.26%	77
2025 Q1	$2.17M	Buy	32,055 +11,890	+59%	+$712K	0.16%	121
2024 Q4	$905K	Buy	+20,165	New	+$1.13M	0.06%	269
2024 Q2	–	Sell	-3,164	Closed	-$252K	–	154
2024 Q1	$252K	Buy	3,164 +415	+15%	+$31.7K	0.06%	84
2023 Q4	$217K	Buy	+2,749	New	+$196K	0.05%	95
2023 Q2	–	Sell	-12,871	Closed	-$956K	–	124
2023 Q1	$956K	Buy	12,871 +10,701	+493%	+$897K	0.23%	63
2022 Q4	$202K	Buy	+2,170	New	+$209K	0.07%	101

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Callan Family Office's CVS Position: Q2 2026 in Review

Callan Family Office reduced its CVS Health (CVS) stake by 0.07% in Q2 2026, selling an estimated $9.64K and leaving 164,995 shares worth $17.1M. The position accounts for 0.33% of the portfolio, ranked #56.

Callan Family Office first reported a position in CVS in Q4 2022 and has held it in 11 quarters since. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Callan Family Office held 164,995 shares of CVS Health worth $17.1M as of Q2 2026.
Callan Family Office sold 108 CVS Health shares in Q2 2026, an estimated $9.64K.
CVS Health made up 0.33% of Callan Family Office's portfolio in Q2 2026, its #56 holding.
Callan Family Office first reported a position in CVS Health in Q4 2022 and has held it in 11 quarters since.
2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.